Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionProspera Financial Services Inc
Latest Disclosed Ownership27,649 shares
Latest Disclosed Value $ 9,733,950
Prospera Financial Services Inc reports 3.07% decrease in ownership of AMGN / Amgen Inc.

On April 14, 2026 - Prospera Financial Services Inc filed a 13F-HR form disclosing ownership of 27,649 shares of Amgen Inc. (MX:AMGN) valued at $9,733,950 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 28,526 shares of Amgen Inc.. This represents a change in shares of -3.07% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F AMGEN COM 031162100 27,649 -877 -3.07 9,734 4.17 0.1568
2026-02-09 2025-12-31 13F AMGEN COM 031162100 28,526 966 3.51 9,343 20.07 0.1534
2025-11-06 2025-09-30 13F AMGEN COM 031162100 27,560 -6,723 -19.61 7,782 -18.74 0.1327
2025-08-06 2025-06-30 13F AMGEN COM 031162100 34,283 1,899 5.86 9,575 -5.12 0.1784
2025-05-15 2025-03-31 13F AMGEN COM 031162100 32,384 -179 -0.55 10,092 18.88 0.2319
2025-02-13 2024-12-31 13F AMGEN COM 031162100 32,563 2,190 7.21 8,489 -13.27 0.1977
2024-11-07 2024-09-30 13F AMGEN COM 031162100 30,373 6,662 28.10 9,788 32.09 0.2500
2024-08-13 2024-06-30 13F AMGEN COM 031162100 23,711 -2,626 -9.97 7,411 -1.07 0.2061
2024-08-13 2024-03-31 13F AMGEN COM 031162100 26,337 -450 -1.68 7,490 -2.92 0.2231
2024-02-14 2023-12-31 13F AMGEN COM 031162100 26,787 511 1.94 7,715 9.22 0.2555
2023-11-13 2023-09-30 13F AMGEN COM 031162100 26,276 -510 -1.90 7,064 18.74 0.2731
2023-08-08 2023-06-30 13F AMGEN COM 031162100 26,786 1,284 5.03 5,949 -3.53 0.2277
2023-05-12 2023-03-31 13F AMGEN COM 031162100 25,502 11,105 77.13 6,167 63.10 0.2535
2023-02-08 2022-12-31 13F AMGEN COM 031162100 14,397 -6,807 -32.10 3,781 -20.92 0.1894
2022-10-27 2022-09-30 13F AMGEN COM 031162100 21,204 406 1.95 4,781 -5.55 0.2495
2022-08-08 2022-06-30 13F AMGEN COM 031162100 20,798 -111 -0.53 5,062 0.08 0.2581
2022-05-04 2022-03-31 13F AMGEN COM 031162100 20,909 2,278 12.23 5,058 20.66 0.2118
2022-02-10 2021-12-31 13F AMGEN COM 031162100 18,631 2,403 14.81 4,192 21.47 0.1812
2021-11-12 2021-09-30 13F AMGEN COM 031162100 16,228 -5,814 -26.38 3,451 -35.77 0.1719
2021-08-16 2021-06-30 13F/A-1 AMGEN COM 031162100 22,042 239 1.10 5,373 -0.96 0.2694
2021-08-12 2021-06-30 13F AMGEN COM 031162100 22,042 239 5,373 0.2766
2021-05-06 2021-03-31 13F AMGEN COM 031162100 21,803 6,143 39.23 5,425 50.69 0.3219
2021-02-12 2020-12-31 13F AMGEN COM 031162100 15,660 13,944 812.59 3,600 725.69 0.2480
2020-11-04 2020-09-30 13F AMGEN COM 031162100 1,716 -13,016 -88.35 436 -87.43 0.1666
2020-08-10 2020-06-30 13F AMGEN COM 031162100 14,732 819 5.89 3,469 23.01 0.3074
2020-05-15 2020-03-31 13F AMGEN COM 031162100 13,913 1,612 13.10 2,820 -4.89 0.2993
2020-02-12 2019-12-31 13F AMGEN COM 031162100 12,301 7,486 155.47 2,965 218.13 0.2284
2019-10-22 2019-09-30 13F AMGEN COM 031162100 4,815 446 10.21 932 15.20 0.0957
2019-08-14 2019-06-30 13F/A-1 AMGEN COM 031162100 4,369 681 18.47 809 12.99 0.0908
2019-08-14 2019-06-30 13F AMGEN COM 031162100 2,613 -1,075 510
2019-05-02 2019-03-31 13F AMGEN COM 031162100 3,688 1,075 41.14 716 40.39 0.2357
2019-02-13 2018-12-31 13F AMGEN COM 031162100 2,613 -230 -8.09 510 -9.89 0.1029
2018-10-25 2018-09-30 13F AMGEN COM 031162100 2,843 221 8.43 566 15.98 0.1055
2018-07-18 2018-06-30 13F AMGEN COM 031162100 2,622 -590 -18.37 488 -11.75 0.0661
2018-04-12 2018-03-31 13F AMGEN COM 031162100 3,212 991 44.62 553 40.36 0.0772
2018-01-23 2017-12-31 13F AMGEN COM 031162100 2,221 -679 -23.41 394 -27.44 0.0602
2017-10-11 2017-09-30 13F AMGEN COM 031162100 2,900 314 12.14 543 22.02 0.0826
2017-07-19 2017-06-30 13F AMGEN COM 031162100 2,586 -243 -8.59 445 -3.68 0.0714
2017-04-13 2017-03-31 13F AMGEN COM 031162100 2,829 758 36.60 462 49.51 0.0833
2017-01-11 2016-12-31 13F AMGEN COM 031162100 2,071 -1,486 -41.78 309 -47.98 0.0605
2016-10-12 2016-09-30 13F AMGEN COM 031162100 3,557 848 31.30 594 44.17 0.1193
2016-07-26 2016-06-30 13F AMGEN COM 031162100 2,709 618 29.56 412 28.35 0.0852
2016-04-12 2016-03-31 13F AMGEN COM 031162100 2,091 2,091 0.00 321 0.0714
2015-04-22 2015-03-31 13F AMGEN COM 031162100 0 -1,558 -100.00 0 -100.00
2015-01-14 2014-12-31 13F AMGEN COM 031162100 1,558 -623 -28.56 248 19.23 0.0618
2014-10-16 2014-09-30 13F AMGEN COM 031162100 2,181 2,181 208 0.0561
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.